Your browser doesn't support javascript.
loading
"Depart from evil, and do good": Turning Axl from uncontrolled tumorigenic gene to biomarker for early detection of pancreatic cancer.
Comandatore, Annalisa; Balsano, Rita; Immordino, Benoit; Arguedas, Davinia; Capula, Mjriam; Baglio, Serena R; Garajovà, Ingrid; Malapelle, Umberto; Morelli, Luca; Giovannetti, Elisa.
Afiliação
  • Comandatore A; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands; General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy.
  • Balsano R; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands; Medical Oncology Unit, University Hospital of Parma, 43100 , Italy.
  • Immordino B; Fondazione Pisana per La Scienza, 56017 San Giuliano, Pisa, Italy.
  • Arguedas D; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands.
  • Capula M; Fondazione Pisana per La Scienza, 56017 San Giuliano, Pisa, Italy.
  • Baglio SR; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands.
  • Garajovà I; Medical Oncology Unit, University Hospital of Parma, 43100 , Italy.
  • Malapelle U; Department of Public Health, University of Naples Federico II, 80131 Naples, Italy.
  • Morelli L; General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56100 Pisa, Italy.
  • Giovannetti E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081HV Amsterdam, The Netherlands; Fondazione Pisana per La Scienza, 56017 San Giuliano, Pisa, Italy. Electronic address: e.giovannetti@amsterdamumc.nl.
Crit Rev Oncol Hematol ; 173: 103659, 2022 May.
Article em En | MEDLINE | ID: mdl-35398264
ABSTRACT
Attempts to achieve early diagnosis are crucial to improve the outcome of patients with pancreatic ductal adenocarcinoma (PDAC). Here we present a critical evaluation of a recent study unraveling the potential of circulating AXL as a novel blood marker for early detection of PDAC and differential diagnosis from chronic pancreatitis (CP).
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Crit Rev Oncol Hematol Ano de publicação: 2022 Tipo de documento: Article